#efta02295569
LightNews LightNews
epsteinweb.bsky.social
EFTA02295569.jpg
#epsteinweb #efta02295569
https://epsteinweb.org
Available in the iOS app store now!
https://apps.apple.com/us/app/epstein-web/id6758880661
EFTA02295528 | EFTA02295569 ConcentRx Investment Thesis • Poised to quickly file IND with unprecedented preclinical data in an area of high unmet medical need - ovarian cancer. • Both components of the dual biotherapy (CIK cells, vaccinia virus) have been extensively vetted by the scientific and regulatory community, and have both been FDA approved for human therapy. • Platform technology play in autologous cell-based immune therapy ■ production of therapy for other partners in the space • joint development deals with companies seeking to develop autologous therapies • own product portfolio ▪ Scientific and management team has a proven track record. DACART CAPITAL LLC EFTA_R1_01138843 EFTA02295569
April 4, 2026 at 3:01 AM